Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator
BOSTON, MA / ACCESSWIRE / January 8, 2025 / Biotech startups often encounter administrative roadblocks on their path to achieving breakthroughs in life sciences. Today, ZAGENO, the leading AI-powered marketplace for lab supplies, and Hatch.Bio Labs, a premier biotech incubator, join forces to eliminate these challenges.
ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
This strategic partnership empowers Hatch.Bio residents with a streamlined lab supply procurement process, allowing them to prioritize groundbreaking research. ZAGENO's platform offers an Amazon-like shopping experience for lab supplies, featuring:
Effortless Management: Discounted rates, easy price comparison of 5,300+ suppliers, single bill-to options, and automated order tracking.
Dedicated Support: Fast onboarding, procurement best practices, and frequent on-site guidance to maximize platform value.
Reduced Costs: Exclusive discounts for Hatch members, with free access for smaller startups.
"Biotech startups are at the forefront of innovation, but administrative hurdles can delay their progress," says Florian Wegener, CEO and Founder of ZAGENO. "Our partnership with Hatch.Bio simplifies lab supply ordering for their members, saving them valuable time and resources."
James Weis, Hatch.Bio CEO, adds, "This collaboration provides our residents with a critical operational advantage, allowing them to streamline operations and accelerate research."
Through this partnership, Hatch.Bio tenants will gain seamless access to ZAGENO's AI-powered lab supply marketplace. By integrating ZAGENO's platform with Hatch.Bio's facilities and support, this collaboration simplifies procurement, automates tracking, and minimizes administrative tasks, freeing researchers to focus on advancing their research to the clinic.
About ZAGENO
ZAGENO is transforming lab supply procurement with the industry's largest AI-powered marketplace, featuring over 40 million products from 5,300+ global suppliers. Scientists, lab managers, and procurement teams rely on ZAGENO's all-in-one platform for painless lab supply procurement that optimizes budgets and enhances productivity. With automated order and delivery tracking, custom workflows, real-time spend analytics, and offloaded supplier management, ZAGENO empowers labs of all sizes to achieve full lab supply ordering automation. Explore ZAGENO's marketplace and discover how it can streamline your lab supply procurement: www.zageno.com or request access at bit.ly/HatchBio-Labs.
About Hatch.Bio Labs
Hatch.Bio Labs is the premier biotechnology and life sciences incubation platform dedicated to reducing operational barriers for biotechnology and life sciences companies. We provide best-in-class, highly flexible, and cost-effective laboratory and office facilities, natively integrated with comprehensive scientific and operational support and strategic partnerships within a modern technology stack-all to help our resident companies grow more rapidly and efficiently. Our mission is to empower biotech pioneers to develop transformative technologies and advance the pace of biotechnology innovation. For more information and to inquire about becoming a tenant, visit www.hatch.bio.
Contact Information
Stephanie Harold
pr@zageno.com
+1 (857) 477-8479
SOURCE: ZAGENO
View the original press release on accesswire.com
ZAGENO
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
BioFi's Phēnix X Family Expands: Revolutionary Phēnix XT, (Phēnix X Tablet), Enters CE Testing Phase, Paving the Way for Global Launch28.4.2025 17:00:00 CEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a leading innovator in biometric authentication and blockchain solutions, is proud to announce a new and innovative Tablet. the Phēnix XT, the latest addition to the groundbreaking Phēnix Family of devices, has completed countrywide evaluations, and has officially entered the CE testing phase. This critical step is anticipated to be completed by June 15, 2025, moving the Phēnix XT closer to global availability. The introduction of the Phēnix XT marks an amazing new development for the Phēnix X platform, opening up a huge opportunity globally, particularly for numerous educational and business applications. Designed to complement the Phēnix X phone and platform, the tablet brings a larger form factor and enhanced capabilities to the secure, decentralized ecosystem. Following successful CE Certification, the Phēnix XT Tablet will be submitted for Type Approval testing in all countries where the Phēnix X phone has alre
BioFi's Revolutionary Phēnix X Blockchain Phone Achieves 4G Type Approval and Certification, Paving the Way for Nigerian Launch28.4.2025 16:00:00 CEST | Press release
WELDON SPRING, MO / ACCESS Newswire / April 28, 2025 / Finnovant Inc., a trailblazing fintech company specializing in mobile technology and biometric authentication solutions, proudly announces that its revolutionary Phēnix X Blockchain phone has successfully attained the coveted 4G Type Approval certification in Nigeria. This significant milestone ensures seamless compatibility with mobile networks across Nigeria and paves the way for launches in other markets across Africa, Southeast Asia, and South America. The BioFi team is thrilled by this achievement as it prepares for the impending launch in the Nigerian market, on the heels of the Nigerian Communications Commissions (NCC) Approvals. The Phēnix X is poised to revolutionize user experiences in Nigeria and other markets, offering advanced security, deep blockchain integration, immersive training capabilities, integrated partner content, and cutting-edge technological advancements. As a leading advocate and pioneer in mobile Blockc
Finnovant Inc. and Storage Chain Announce Industry-First PhenixLoc Data Manager Launch, Bringing Unprecedented Security and Innovative Features with Affordable Decentralized Storage to Emerging Markets28.4.2025 15:00:00 CEST | Press release
MOUNTAIN VIEW, CA / ACCESS Newswire / April 28, 2025 / Finnovant, a leader in mobile technology and biometric authentication solutions, and Storage Chain, a pioneer in decentralized storage technology, today announced the upcoming launch of the PhēnixLoc Data Manager, set for June 1, 2025. This groundbreaking product utilizing Web 3 technology is poised to revolutionize data security and accessibility, particularly for underbanked and unbanked individuals in emerging markets, offering an industry-first combination of advanced security, user control, and affordability on Android, iOS, and through Browsers on any device. The PhēnixLoc Data Manager provides encrypted, decentralized storage for all types of private or sensitive information. Built with the specific needs of emerging markets in mind, it delivers incredible security and pricing designed to be accessible and affordable for anyone. Access to PhēnixLoc is through Web 3 decentralized technology and secured by Say-Tec, Finnovant's
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens28.4.2025 14:00:00 CEST | Press release
LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year. Funded by the National Institute on Aging (NIA), part of the U.S. National Institutes of Health (NIH), the platform trial is supported by a five-year grant. Its design enables multiple therapies to be tested concurrently, establishing a perpetual, efficient and flexible path to evaluate promisin
SYNLawn Welcomes Romania’s First Official SYNLawn Distributor27.4.2025 10:00:00 CEST | Press release
POPEŞTI-LEORDENI, RO / ACCESS Newswire / April 27, 2025 / SYNLawn, a global manufacturer and innovator of bio-based synthetic turf, announced its expansion into a new international market with the launch SYNLawn Romania. The company will carry SYNLawn's premium line of synthetic turf and surfacing products as the first official and exclusive distributor in Romania. "Our newest official partner is dedicated to bringing premium artificial turf solutions to the Romanian market," said George Neagle, president of SYNLawn Global. "With a strong focus on landscaping, golf, and commercial applications, SYNLawn Romania is set to redefine outdoor spaces in its region with high-quality, durable, and environmentally friendly artificial grass." The company started its business in 2022 and is based in Popești-Leordeni, just 9 kilometers from Bucharest. SYNLawn Romania specializes in the distribution of premium landscaping products. While new to the artificial turf sector, the company has a solid fou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom